Wai Chun Bio-Technology (HKG:0660) plans to reduce its issued share capital by canceling its paid-up capital, according to a Friday filing with the Hong Kong Stock Exchange.
The cancellation involves reducing the par value of the modified starch and other biochemical product company's issued common shares to HK$0.01 each from HK$0.25.
After the capital reduction, the company will subdivide its unissued shares with a par value of HK$0.25 each into 25 new common shares with a par value of HK$0.01 each.
The company also agreed with bondholders to amend the terms of its existing convertible bonds, including changing the conversion price to HK$0.06 per conversion share from HK$0.25 as well as extending their maturity dates.
Price (HKD): $0.07, Change: $+0.0010, Percent Change: +1.56%
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。